Lilly Campuses

The Branchburg Campus of Eli Lilly and Company is a key R&D and manufacturing hub, offering specialized training programs akin to advanced university courses in bioprocessing, analytical chemistry, and product development within the pharmaceutical industry. These initiatives aim to enhance technical expertise and operational efficiency for teams working on biologics and small molecule production.

• Bioprocess Engineering: Courses detailing upstream and downstream processing, cell culture optimization, and scale-up strategies for biologics manufacturing.
• Analytical Method Development: Training in spectroscopy, chromatography, and mass spectrometry techniques for quality control and stability testing.
• Supply Chain and Manufacturing Excellence: Modules on lean manufacturing, GMP compliance, and logistics in pharmaceutical supply chains.
• Formulation Science: In-depth studies on drug delivery systems, excipient selection, and stability enhancement for various therapeutic modalities.
• Quality Systems Management: Comprehensive coverage of ISO standards, audit preparation, and risk-based quality management in pharma operations.

At this campus, learners participate in laboratory-based simulations and pilot-scale projects that replicate real-world manufacturing scenarios. The programs integrate theoretical knowledge with practical skills, drawing from Lilly's extensive portfolio in areas like immunology and neuroscience. Approximately 250 hours of structured coursework are available, including certifications in biomanufacturing and analytical validation. External collaborations with academic institutions enrich the curriculum, bringing in guest lectures on emerging technologies such as continuous manufacturing and AI in process optimization.

The campus also emphasizes sustainability in pharma production, with courses on green chemistry and waste reduction strategies. This educational framework supports Eli Lilly's commitment to innovation, ensuring that professionals are adept at developing high-quality, life-saving medications efficiently and responsibly.

The Greenfield Campus, part of Eli Lilly's Indiana network, specializes in animal health and biologics training programs that function like specialized graduate-level courses in veterinary pharmaceuticals, vaccine development, and biopharmaceutical production. This site supports Lilly's animal health division, focusing on innovative solutions for livestock and companion animals.

• Veterinary Pharmacology: Courses on pharmacodynamics, toxicology, and therapeutic applications for animal health products.
• Vaccine Development and Immunology: Training in antigen design, adjuvant formulation, and immunogenicity testing for veterinary vaccines.
• Biologics Manufacturing: Modules covering fermentation processes, purification techniques, and aseptic filling for animal biologics.
• Regulatory Science for Animal Health: In-depth exploration of USDA and FDA guidelines specific to veterinary medicines and compliance strategies.
• Product Lifecycle Management: Sessions on R&D to commercialization, including market analysis and post-market surveillance in the animal health sector.

Hands-on training at this campus includes work with pilot bioreactors and animal model studies, providing practical experience in a controlled environment. The curriculum spans over 280 hours, with emphasis on ethical animal research and sustainable practices. Collaborations with veterinary schools offer joint programs, enhancing the academic rigor and real-world applicability of the courses.

Key therapeutic areas covered include infectious diseases, endocrinology, and dermatology for animals, aligning with Lilly's global animal health initiatives. These programs not only build internal capabilities but also serve as a resource for industry professionals, fostering advancements in animal welfare and food security through superior pharmaceutical solutions.

The Lebanon Campus is Eli Lilly's state-of-the-art manufacturing facility, delivering training programs equivalent to industrial engineering and operations management courses tailored to pharmaceutical production. It emphasizes high-volume manufacturing of injectable and oral dosage forms, preparing personnel for efficient, compliant operations.

• Pharmaceutical Manufacturing Processes: Courses on tablet compression, coating, and sterile filling techniques for solid and liquid dosage forms.
• Automation and Process Control: Training in PLC programming, SCADA systems, and Industry 4.0 applications in pharma manufacturing.
• Validation and Qualification: Modules on equipment IQ/OQ/PQ, process validation, and cleaning validation protocols.
• Sterile Operations and Aseptic Processing: In-depth studies on environmental monitoring, media fills, and contamination control in cleanrooms.
• Lean Six Sigma in Pharma: Practical applications of continuous improvement methodologies to enhance production efficiency and reduce variability.

Participants engage in on-site simulations using actual production lines, accumulating over 300 hours of training that includes certification in cGMP and process engineering. The programs incorporate case studies from Lilly's blockbuster products, highlighting scalability and quality assurance challenges.

This campus also addresses supply chain resilience and digital transformation, with courses on blockchain for traceability and predictive maintenance using AI. By focusing on these areas, the Lebanon site contributes to Lilly's goal of reliable drug supply, ensuring that manufacturing excellence supports patient access to critical therapies worldwide.

The Lilly Corporate Center in Indianapolis serves as the global headquarters for Eli Lilly and Company, focusing on a wide array of professional development and specialized training programs that mirror academic courses in the pharmaceutical and biotechnology sectors. These programs are designed to equip employees and partners with cutting-edge knowledge in drug discovery, clinical trials, and regulatory affairs.

• Pharmaceutical Sciences: In-depth courses on medicinal chemistry, pharmacology, and biopharmaceutical development, covering topics from molecular modeling to advanced drug formulation techniques.
• Clinical Research Management: Training in designing and executing clinical trials, including ethical considerations, data analysis, and compliance with FDA regulations.
• Business and Leadership in Biotech: Courses exploring corporate strategy, innovation management, and leadership skills tailored to the life sciences industry.
• Regulatory Affairs and Compliance: Comprehensive modules on global regulatory frameworks, quality assurance, and pharmacovigilance to ensure product safety and efficacy.
• Biotechnology and Bioinformatics: Advanced sessions on genetic engineering, genomics, and computational biology, with hands-on applications in personalized medicine.

Participants engage in interactive workshops, case studies from real Lilly projects, and collaborative projects that simulate industry challenges. The curriculum emphasizes interdisciplinary approaches, integrating science, technology, and business to foster innovation. Over 300 hours of content are delivered annually, with certifications recognized in the pharma sector. This campus also hosts executive education programs for external professionals, promoting knowledge exchange and advancing the field of healthcare innovation. Through these offerings, the center contributes to Eli Lilly's mission of improving global health outcomes by building a skilled workforce capable of tackling complex medical challenges.

Additional focus areas include neuroscience research training, diabetes management education, and oncology therapeutics development, ensuring a holistic understanding of therapeutic areas where Lilly excels. The programs are continually updated to reflect the latest scientific advancements and industry trends, providing a dynamic learning environment that supports career growth and organizational excellence.

The Spencer Campus, a dedicated biologics manufacturing site for Eli Lilly, offers advanced training programs resembling bioengineering and microbiology courses, centered on large-scale production of monoclonal antibodies and other recombinant proteins. This facility plays a crucial role in Lilly's biologics pipeline.

• Mammalian Cell Culture Technology: Courses on bioreactor design, media optimization, and harvest processes for CHO cell-based production.
• Downstream Purification: Training in chromatography, filtration, and viral clearance methods for biologics isolation.
• Microbial Fermentation: Modules covering bacterial and yeast expression systems, scale-up, and product recovery.
• Biopharmaceutical Analytics: In-depth techniques for characterization, including HPLC, ELISA, and glycan analysis.
• Facility Design and Operations: Sessions on cleanroom engineering, HVAC systems, and biosafety level management.

With hands-on access to production suites, the training exceeds 290 hours, featuring simulations of tech transfers and process improvements. Certifications in bioprocess technology are awarded, drawing from Lilly's expertise in oncology and immunology biologics.

The curriculum integrates sustainability, covering energy-efficient manufacturing and waste minimization. External experts contribute to topics like next-gen bioprocessing and PAT (Process Analytical Technology). This educational hub strengthens Lilly's capacity to deliver innovative biologics, advancing treatments for complex diseases.